The antibiotic-resistant Acinetobacter baumannii bacterium is one of the most globally harmful bacteria that causes hospital-acquired infections. Researchers at the University of Turku have discovered that the bacterium spreads by attaching to surfaces using ultrathin stretchy fibers. The researchers also revealed how these fibers are formed on the bacterial surface and suggested new approaches to prevent bacterial infections. The new findings have been published in Nature, one of the leading scientific journals in the World.
Researchers create new, unparallelled supramolecular plastic which is degradable and highly recyclable
A research group headed by senior researcher Jianwei Li at the MediCity Research Laboratory has explored a new type of materials called supramolecular plastics that would substitute the conventional polymeric plastics with an eco-friendlier material promoting sustainable development. The mechanical properties of the supramolecular plastic created by the researchers using liquid-liquid phase separation were comparable to conventional polymers, but the new plastic decomposes much more easily and would be easier to reuse.
Sigrid Jusélius Foundation has announced the outcome of the application of Senior Researcher grants in 2021. Dr. Jianwei Li, a group leader at the MediCity Research Laboratory, is one of the five awardees, and will receive 700 000 € to develop nanomaterials for cancer therapy from a systems chemistry perspective.
The Cancer Biology laboratories of Klaus Elenius and Kari Kurppa are looking for a doctoral candidate to join a collaborative project of the two laboratories in the University of Turku, Turku, Finland.
Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body’s phagocytes and facilitates extensive activation of the immune system.
This year, the Elias Tillandz prize for the best scientific paper published in 2019 in BioCity Turku has been awarded to Academician Sirpa Jalkanen and her research group.
The Cancer Drug Resistance laboratory is looking for two doctoral candidates to join a new and exciting research group in the University of Turku, Turku, Finland.
Glucocorticoids, which are widely used as treatment in intensive care, can nearly quadruple the death rate of patients suffering from acute respiratory distress syndrome. Researchers at the University of Turku, Finland, discovered the reason for the higher mortality. The findings are also important in the fight against COVID-19 disease.